Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
The Journal of Experimental Medicine|May 5, 2021
Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patientsCarole Le Coz, David N Nguyen, Chun Su, et al.The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.Pediatrics|January 19, 2017
Newborn Sequencing in Genomic Medicine and Public HealthJonathan S Berg, Pankaj B Agrawal, Donald B Bailey, et al.Nature Immunology|February 6, 2019
An essential role for the Zn<sup>2+</sup> transporter ZIP7 in B cell developmentConsuelo Anzilotti, David J Swan, Bertrand Boisson, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2026
ASSESSMENT OF TREC-BASED NBS SCID REPORTING PRACTICES FOR HARMONIZATION OF RESULTS AND INTERPRETATION: A GLOBAL SURVEYJahnavi Aluri, Amy Gaviglio, Isaac Kistler, et al.The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.Pageof 16